Naratriptan Hydrochloride | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Naratriptan Hydrochloride
Canada

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Naratriptan Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 2 JDMF, 8 EU WC, 3 KDMF, 4 NDC API, 6 Listed Suppliers, $ API Reference Price

12 API Suppliers
6 USDMF
2 JDMF
8 EU WC
3 KDMF
4 NDC API
6 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 19 FDA Orange Book, 1 Europe, 3 Canada

23 FDF Dossiers
19 FDA Orange Book
1 Europe
3 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 24 Direct Compression, 21 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 15 Granulation, 14 Co-Processed Excipients, 13 Thickeners and Stabilizers, 13 Lubricants & Glidants, 9 Film Formers & Plasticizers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 2 Topical, 2 Parenteral, 1 Solubilizers, 1 Surfactant & Foaming Agents

50 Fillers, Diluents & Binders
44 Coating Systems & Additives
24 Direct Compression
21 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
15 Granulation
14 Co-Processed Excipients
13 Thickeners and Stabilizers
13 Lubricants & Glidants
9 Film Formers & Plasticizers
5 Empty Capsules
4 Emulsifying Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Coloring Agents
3 Chewable & Orodispersible Aids
2 Topical
2 Parenteral
1 Solubilizers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

1 US Medicaid Prescriptions
4 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 34,098 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 1SANDOZ CANADA INCORPORATED

02 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

3 All

01 3NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE)

filter Dosage Form Reset all filters

3 All

01 3TABLET

filter Brand Name Reset all filters

3 All

01 1SANDOZ NARATRIPTAN

02 2TEVA-NARATRIPTAN

List of Suppliers

Product Main Page

01

SANDOZ CANADA INCORPORATED

PharmaVenue

Not Confirmed

SANDOZ CANADA INCORPORATED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE)

Brand Name : SANDOZ NARATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 7

Approval Date :

Application Number : 2322323

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

02

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE)

Brand Name : TEVA-NARATRIPTAN

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging : 8/60/100

Approval Date :

Application Number : 2314290

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

TEVA CANADA LIMITED

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE)

Brand Name : TEVA-NARATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 60/100

Approval Date :

Application Number : 2314304

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?